You are here

Thalomid

Should Biogen and Shire investors be wary of the latest patent challenges?

Bizjournals.com

Thu, 04/23/15 - 04:56 pm

Mylan sues Celgene for blocking Revlimid, Thalomid generics

Yahoo/Reuters

Fri, 04/4/14 - 09:18 am

Celgene's Multiple Myeloma Powerhouse

Motley Fool

Thu, 08/22/13 - 11:21 am

Multiple Myeloma

Celgene says Teva division Barr withdrew cancer drug application, Celgene dropped patent suit

Yahoo/AP

Thu, 05/27/10 - 10:07 am

Teva Pharmaceuticals

Barr Laboratories

Celgene's Healthy Outlook

Yahoo/Zacks.com

Fri, 01/2/09 - 10:52 am